183 related articles for article (PubMed ID: 35472849)
21. Design, synthesis and antibacterial evaluation of novel pleuromutilin derivatives possessing piperazine linker.
Gao ML; Zeng J; Fang X; Luo J; Jin Z; Liu YH; Tang YZ
Eur J Med Chem; 2017 Feb; 127():286-295. PubMed ID: 28068600
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of novel pleuromutilin derivatives containing benzimidazoles as effective anti-MRSA agents.
Zhang QW; Ren J; Lu JX; Chen XY; He XJ; Wang Q; Zhou ZD; Jin Z; Zeng ZL; Tang YZ
Drug Dev Res; 2023 Nov; 84(7):1437-1452. PubMed ID: 37534779
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis and biological evaluation of novel pleuromutilin derivatives containing piperazine and 1,2,3-triazole linker.
Zhang GY; Zhang Z; Li K; Liu J; Li B; Jin Z; Liu YH; Tang YZ
Bioorg Chem; 2020 Dec; 105():104398. PubMed ID: 33137559
[TBL] [Abstract][Full Text] [Related]
24. Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Pleuromutilin Derivatives Containing Thiazole.
Li K; Lin C; Hu YH; Wang J; Jin Z; Zeng ZL; Tang YZ
ACS Infect Dis; 2024 Jun; 10(6):1980-1989. PubMed ID: 38703116
[TBL] [Abstract][Full Text] [Related]
25. Antibiotic resistance and drug modification: Synthesis, characterization and bioactivity of newly modified potent pleuromutilin derivatives with a substituted piperazine moiety.
Yi Y; Yang S; Liu Y; Yin B; Zhao Z; Li G; Huang Z; Chen L; Liu F; Shang R; Lin S
Bioorg Chem; 2023 Mar; 132():106353. PubMed ID: 36669358
[TBL] [Abstract][Full Text] [Related]
26. Novel pyridinium cationic pleuromutilin analogues overcoming bacterial multidrug resistance.
Yi Y; Zhang J; Zuo J; Zhang M; Yang S; Huang Z; Li G; Shang R; Lin S
Eur J Med Chem; 2023 May; 251():115269. PubMed ID: 36924667
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and antibacterial activities of novel pleuromutilin derivatives.
Yi Y; Fu Y; Wang K; Shui Y; Cai J; Jia Z; Niu B; Liang J; Shang R
Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800155. PubMed ID: 30058185
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and biological activities of novel pleuromutilin derivatives with a substituted triazole moiety as potent antibacterial agents.
Zhang Z; Li K; Zhang GY; Tang YZ; Jin Z
Eur J Med Chem; 2020 Oct; 204():112604. PubMed ID: 32731187
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biological activities and docking studies of pleuromutilin derivatives with piperazinyl urea linkage.
Zhang Y; Xie C; Liu Y; Shang F; Shao R; Yu J; Wu C; Yao X; Liu D; Wang Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):764-775. PubMed ID: 33733986
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, biological activities, and docking study of novel chalcone-pleuromutilin derivatives.
Xie C; Zhang S; Zhang W; Wu C; Yong C; Sun Y; Zeng Z; Zhang Q; Huang Z; Chen T; Zhang Y
Chem Biol Drug Des; 2020 Aug; 96(2):836-849. PubMed ID: 32271987
[TBL] [Abstract][Full Text] [Related]
31. Chemical synthesis and biological activities of novel pleuromutilin derivatives with substituted amino moiety.
Shang R; Wang S; Xu X; Yi Y; Guo W; Yuliu ; Liang J
PLoS One; 2013; 8(12):e82595. PubMed ID: 24376551
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of pleuromutilin-Schiff base hybrids as potent anti-MRSA agents in vitro and in vivo.
Li B; Zhang Z; Zhang JF; Liu J; Zuo XY; Chen F; Zhang GY; Fang HQ; Jin Z; Tang YZ
Eur J Med Chem; 2021 Nov; 223():113624. PubMed ID: 34153574
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antibacterial evaluation of novel pleuromutilin derivatives.
Shang R; Liu Y; Xin Z; Guo W; Guo Z; Hao B; Jianping L
Eur J Med Chem; 2013 May; 63():231-8. PubMed ID: 23501109
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and Pharmacological Evaluation of Novel Pleuromutilin Derivatives with Substituted Benzimidazole Moieties.
Ai X; Pu X; Yi Y; Liu Y; Xu S; Liang J; Shang R
Molecules; 2016 Nov; 21(11):. PubMed ID: 27834819
[TBL] [Abstract][Full Text] [Related]
35. In Vitro and In Vivo Activity of 14-
Fu Y; Leng C; Fan Y; Ma X; Li X; Wang X; Guo Z; Wang X; Shang R
Molecules; 2021 May; 26(11):. PubMed ID: 34071703
[No Abstract] [Full Text] [Related]
36. Novel pleuromutilin derivatives with excellent antibacterial activity against Staphylococcus aureus.
Xu P; Zhang YY; Sun YX; Liu JH; Yang B; Wang YZ; Wang YL
Chem Biol Drug Des; 2009 Jun; 73(6):655-60. PubMed ID: 19635057
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial activity evaluation of pleuromutilin derivatives with 4(3H)-quinazolinone scaffold against methicillin-resistant Staphylococcusaureus.
Deng Y; Zhang Y; Chen XH; Li CH
Eur J Med Chem; 2023 Jan; 246():114960. PubMed ID: 36462445
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and antibacterial evaluation of pleuromutilin derivatives.
Wu G; Zhu Z; Li J; Luo X; Zhu W; Liao G; Xia J; Zhang W; Pan W; Li T; Wu S
Bioorg Med Chem; 2022 Apr; 59():116676. PubMed ID: 35220163
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and antibacterial activity of pleuromutilin derivatives.
Liu HX; Yao WY; Cui G; Zhou J; Yan H; Guo H; Wang YW; Zhang Y
Chem Biol Drug Des; 2024 Jun; 103(6):e14554. PubMed ID: 38806405
[TBL] [Abstract][Full Text] [Related]
40. Novel pleuromutilin derivatives as antibacterial agents: synthesis, biological evaluation and molecular docking studies.
Wang X; Ling Y; Wang H; Yu J; Tang J; Zheng H; Zhao X; Wang D; Chen G; Qiu W; Tao J
Bioorg Med Chem Lett; 2012 Oct; 22(19):6166-72. PubMed ID: 22932314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
